Fluocinolone Acetonide (Capex)

Subscribe to Selected New Research on Fluocinolone Acetonide

199 relevant articles (12 outcomes, 24 trials/studies) found for this Drug

Description: A glucocorticoid derivative used topically in the treatment of various skin disorders. It is usually employed as a cream, gel, lotion, or ointment. It has also been used topically in the treatment of inflammatory eye, ear, and nose disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732)

Also Known As:

Capex; Synalar; Fluonid; Fluotrex; Allergan Brand of Fluocinolone Acetonide; Alvadermo; Bioglan Brand of Fluocinolone Acetonide; Centrum Brand of Fluocinolone Acetonide; Co-Fluocin; Cortiespec; Derma-Smooth/FS; Flucinar; Fluocid; Fluodermo; Flurosyn; Flusolgen; Galderma Brand of Fluocinolone Acetonide; Gelidina; Geni Brand of Fluocinolone Acetonide; Grünenthal Brand of Fluocinolone Acetonide; Hill Brand of Fluocinolone Acetonide; Inexfa Brand of Fluocinolone Acetonide; Inkeysa Brand of Fluocinolone Acetonide; Jellin; Jellisoft; Medicis Brand 1 of Fluocinolone Acetonide; Medicis Brand 2 of Fluocinolone Acetonide; Rugby Brand of Fluocinolone Acetonide; Savage Brand of Fluocinolone Acetonide; Septa Brand of Fluocinolone Acetonide; Smaller Brand of Fluocinolone Acetonide; Synalar-HP; Synamol; Synemol; Syntex Brand of Fluocinolone Acetonide; Yamanouchi Brand of Fluocinolone Acetonide; medphano Brand of Fluocinolone Acetonide; Acetonide, Fluocinolone; Acetonide, Fluortriamcinolone; Co Fluocin; Derma Smooth/FS; Synalar HP; Fluortriamcinolone Acetonide; Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6alpha,11beta,16alpha)-

Relationship Network

Drug Context: Research Results

Experts

1.	Jaffe, Glenn J: 7 articles (10/2008 - 07/2005)
2.	Pearson, P Andrew: 3 articles (09/2008 - 06/2006)
3.	Callanan, David G: 2 articles (09/2008 - 11/2007)
4.	Comstock, Timothy L: 2 articles (09/2008 - 11/2007)
5.	Ashton, Paul: 2 articles (07/2006 - 07/2005)
6.	Chieh, Janet J: 1 article (10/2008)
7.	Carlson, Alan N: 1 article (10/2008)
8.	Nussenblatt, Robert B: 1 article (09/2008)
9.	Tsai, T-H: 1 article (09/2008)
10.	Park, K C: 1 article (09/2008)

Related Diseases

1.	Psoriasis (Pustulosis Palmaris et Plantaris) 12/01/2004 - "This study also showed that the vehicle alone causes an improvement in the signs of psoriasis, but that the addition of 0.1% of the low potency steroid, fluocinolone acetonide, leads to a significantly better improvement." 12/01/2004 - "This study was designed to demonstrate the efficacy, tolerance and safety of fluocinolone acetonide 0.01% in oil, compared to its vehicle, for the treatment of scalp psoriasis. " 12/01/2004 - "Fluocinolone acetonide topical oil for scalp psoriasis." 01/01/1997 - "We monitored the level of SOD and TAS in 7 males with psoriasis and 6 control subjects before and after a single application of fluocinolone acetonide 0.025% ointment to 90% of the body. " 06/01/1990 - "[Evaluation of effectiveness and safety and quantitative evaluation of the use of fluocinolone acetonide in cream (0.025%) and medicated tape (8 micrograms/cm2) in the treatment of psoriasis]" Order ALL the reference details at left...
2.	Oral Lichen Planus 01/01/2000 - "CONCLUSION: Fluocinolone acetonide gel 0.1% is a safe and effective alternative therapy to fluocinolone acetonide in an oral base 0.1% in the treatment of oral lichen planus." 01/01/2000 - "Efficacy of fluocinolone acetonide gel in the treatment of oral lichen planus." 07/01/2003 - "Clinical evaluation in treatment of oral lichen planus with topical fluocinolone acetonide: a 2-year follow-up." 01/01/2000 - "The results indicate that fluocinolone acetonide gel no. 1 and no. 2 and fluocinolone acetonide in an oral base provide similar efficacy in the treatment of oral lichen planus. " 01/01/1997 - "The results suggest that 0.1% fluocinolone acetonide reduced the severity of atrophic and erosive oral lichen planus better than 0.05% retinoic acid." Order ALL the reference details at left...
3.	Posterior Uveitis 09/01/2008 - "OBJECTIVES: To evaluate the safety and efficacy of 0.59-mg and 2.1-mg fluocinolone acetonide (FA) intravitreous implants in noninfectious posterior uveitis. " 07/01/2005 - "PURPOSE: To investigate the safety and efficacy of a fluocinolone acetonide intravitreal implant in the treatment of noninfectious posterior uveitis. " 06/01/2006 - "PURPOSE: To report the interim 34-week safety and efficacy results of a 3-year study to evaluate an investigational intravitreal fluocinolone acetonide (FA) implant in patients with noninfectious posterior uveitis. " 06/01/2006 - "Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study." 07/01/2005 - "Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis." Order ALL the reference details at left...
4.	Uveitis 07/01/2006 - "Efficacy of low-release-rate fluocinolone acetonide intravitreal implants to treat experimental uveitis." 11/01/2000 - "In this report, we describe a pilot safety and efficacy trial of a novel sustained drug delivery system containing fluocinolone acetonide to treat patients with severe uveitis. " 09/01/2009 - "Three patients with chronic, noninfectious uveitis requiring immunosuppressive therapy underwent fluocinolone acetonide (FA) implant exchange complicated by dissociation of the medication reservoir from its anchoring strut. " 03/01/2009 - "PURPOSE OF REVIEW: The fluocinolone acetonide intravitreal implant was approved by the United States Food and Drug Administration in April, 2005 for treatment of noninfectious posterior segment uveitis (NIPU). " 01/01/2009 - "Uveitis treated with fluocinolone acetonide implants." Order ALL the reference details at left...
5.	Atopic Dermatitis (Atopic Eczema) 04/01/2003 - "OBJECTIVE: We sought to study the effectiveness for atopic dermatitis, potential for adrenal axis suppression, and safety of the fluocinolone acetonide 0.01% in oil in children with atopic dermatitis, including children with atopic dermatitis and peanut allergic sensitivity. " 02/01/1969 - "Fluocinolone acetonide in atopic dermatitis." 03/01/1963 - "The treatment of infantile eczema with fluocinolone acetonide cream." 05/01/2009 - "Fluocinolone acetonide 0.01% in a blend of refined peanut and mineral oils has been established as effective and safe treatment for atopic dermatitis in patients 2 years and older, including those with peanut sensitivity, for several years. " 05/01/2009 - "Results of this study support the safety and efficacy of fluocinolone acetonide 0.01% in refined peanut oil vehicle, for infants as young as 3 months of age with atopic dermatitis. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Triamcinolone Acetonide (Azmacort)
2.	Tretinoin (Retinoic Acid)
3.	arachis oil
4.	Adrenal Cortex Hormones (Corticosteroids)
5.	Propylene Glycol (1,2 Propanediol)
6.	Oils
7.	Doxorubicin (Adriamycin)
8.	Dimethyl Sulfoxide (DMSO)
9.	Betamethasone 17-Valerate (Betamethasone 17 Valerate)
10.	efalizumab

Related Therapies and Procedures

1.	Occlusive Dressings (Occlusive Dressing)
2.	Replantation
3.	Laser Therapy (Surgery, Laser)
4.	Withholding Treatment
5.	Intraocular Lens Implantation

Best Treatments:
Research Summary Report
on Psoriasis

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 1387 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>